Molecular characterisation of the causative agents of Cryptococcosis in patients of a tertiary healthcare facility in the state of Amazonas-Brazil

Mycoses

Volumn 55, Issue 3, 2012, Pages

  Freire, Ana Karla Lima ^a   dos Santos Bentes, Amaury ^b   de Lima Sampaio, Ivanete ^a   Matsuura, Ani Beatriz Jackisch ^c   Ogusku, Maurício Morishi ^b   Salem, Julia Ignez ^b   Wanke, Bodo ^a,c   de Souza, João Vicente Braga ^a,b  

^a UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

^b INSTITUTO NACIONAL DE PESQUISAS DA AMAZÔNIA   (Brazil)

^c Funda??o Oswaldo Cruz   (Brazil)

Author keywords

Cryptococcus; Genotyping; ITS1 RFLP analysis; M13; PCR fingerprinting; URA5 RFLP

Indexed keywords

FUNGAL PROTEIN; UNCLASSIFIED DRUG; URA5 PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CEREBROSPINAL FLUID; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; DNA FINGERPRINTING; FEMALE; FUNGAL GENE; FUNGUS ISOLATION; GENE EXPRESSION; GENE LOCUS; HEALTH CARE FACILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SPECIES DIVERSITY; TERTIARY HEALTH CARE; VARIABLE NUMBER OF TANDEM REPEAT; VIRUS ISOLATION;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE FACILITIES; BRAZIL; CHILD; CHILD, PRESCHOOL; CRYPTOCOCCOSIS; CRYPTOCOCCUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYCOLOGICAL TYPING TECHNIQUES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; YOUNG ADULT;

CRYPTOCOCCUS GATTII; FILOBASIDIELLA NEOFORMANS;

EID: 84860003863     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2012.02173.x     Document Type: Article

References (30)

1. Bovers M, Hagen F, Boekhout T. Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev Iberoam Micol 2008; 25: S4-12.
2. Diamond RD. Cryptococcus neoformans. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995: 2331-40.
3. Katsu M, Kidd S, Ando A et al. The internal transcribed spacers and 5.8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex. FEMS Yeast Research 2004; 4: 377-88.
4. Kidd SE, Hagen F, Tscharke RL. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A 2004; 172: 58-63.
5. Nishikawa MM, Lazéra MS, Barbosa GG. Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns. J Clin Microbiol 2003; 41: 73-7.
6. Aoki FH, Imai T, Tanaka R et al. New PCR primer pairs specific for Cryptococcus neoformans serotype A or B prepared on the basis of random amplified polymorphic DNA fingerprint pattern analyses. J Clin Microbiol 1999; 37: 315-20.
7. Kwon-Chung KJ, Boekhout T, Fell JW, Diaz M. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon 2002; 51: 804-6.
8. Meyer W, Marszewska K, Amirmostofina M et al. Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA - a pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis 1999; 20: 1790-9.
9. Meyer W, Castañeda A, Huynh JS, Castañeda E, IberoAmerican Cryptococcal Study Group. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 2003; 9: 189-95.
10. Irobi J, Schoofs A, Goossens H. Genetic identification of Candida species in HIV-positive patients using the polymerase chain reaction and restriction fragment length polymorphism analysis of its DNA. Molec Cell Prob 1999; 14: 401-6.
11. Lo Passo C, Pernice I, Gallo M et al. Genetic relatedness and diversity of Cryptococcus neoformans strains in the Maltese islands. J Clin Microbiol 1997; 35: 751-5.
12. Santos MS, Souza ES, Junior RMS, Talhari S, Souza JVB. Identification of fungemia agents using the polymerase chain reaction and restriction fragment length polymorphism analysis. Braz J Med Biol Res 2010; 43: 712-6.
13. Selvarangan R, Limaye AP, Cookson BT. Rapid identification and differentiation of Candida albicans and Candida dubliniensis by capillary-based amplification and fluorescent probe hybridization. J Clin Microbiol 2002; 40: 4308-12.
14. Liaw SJ, Wu HC, Hsueh PR. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility. Clin Microbiol Infect 2009; 16: 696-703.
15. Souza LK, Souza Junior AH, Costa CR et al. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil. Mycoses 2010; 53: 62-7.
16. Chaturvedi S, Rodeghier B, Fan J, Mcclelland CM, Wickes BL, Chaturvedi V. Direct PCR of Cryptococcus neoformans MATa and MATa pheromones to determine mating type, ploidy, and variety: a tool for epidemiological and molecular pathogenesis studies. J Clin Microbiol 2000; 38: 2007-9.
17. Santos WRA, Meyer W, Wanke B et al. Primary endemic Cryptococcosis gattii by molecular type VGII in the state of Pará, Brazil. Mem Inst Oswaldo Cruz 2008; 103: 813-8.
18. Trilles L, Lazéra MS, Wanke B et al. Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil. Mem Inst Oswaldo Cruz 2008; 103: 455-62.
19. Casali AK, Goulart L, Silva LKR et al. Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul. FEMS Yeast Res 2003; 3: 405-15.
20. Silva BKS. Caracterização de linhagens do complexo Cryptococcus neoformans isoladas de pacientes atendidos na Fundação de Medicina Tropical do Amazonas. Dissertação de Mestrado. Manaus: Universidade do Estado do Amazonas, 2009: 92.
21. D'Souza CA, Hagen F, Boekhout T, Cox GM, Heitman J. Investigation of the basis of virulence in serotype A strains of Cryptococcus neoformans from apparently immunocompetent individuals. Curr Genet 2004; 46: 92-102.
22. Matsumoto MT, Fusco-Almeida AM, Baeza LC, Melhem MSC, Mendes-Giannini MJS. Genotipagem, sorotipagem e determinação de mating-type de isolados clínicos de Cryptococcus neoformans do Estado de São Paulo, Brasil. Rev Inst Med Trop S Paulo 2007; 39: 3-6.
23. Santos WRA, Meyer W, Wanke B et al. Primary endemic Cryptococcosis gattii by molecular type VGII in the state of Pará, Brazil. Mem Inst Oswaldo Cruz 2008; 103: 813-8.
24. Brandt ME, Hutwagner LC, Klug LA et al. Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. J Clin Microbiol 1996; 34: 912-7.
25. Steenbergen JN, Casadevall A. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect 2003; 5: 667-75.
26. Ministério da Saúde do Brasil. Documentos e publicações em DST e AIDS. Coordenação do programa nacional de DTS/AIDS. Vigilância Eidemiológica, 2004. Disponível em: Acesso em: 22.03.2009
27. Santos LO. Criptococose no estado do Amazonas: estudo de 75 casos diagnosticados na Fundação de Medicina Tropical/FMT/IMTM, Manaus, AM (1988-1998), Dissertação de Mestrado. Rio de Janeiro: Instituto Oswaldo Cruz-Fiocruz, 2000: 154.
28. Correa MP, Oliveira EC, Duarte RR, Pardal PP, Oliveira FM, Severo LC. Cryptococcosis in children in the state of Pará, Brazil. Rev Soc Bras Med Trop 1999; 32: 505-8.
29. Martins LMS. Epidemiologia da criptococose em crianças e adultos jovens e diversidade de Cryptococcus neoformans no Meio Norte do Brasil. Dissertação de Mestrado. Rio de Janeiro: Instituto Oswaldo Cruz, 2003: 87.
30. Durden FM, Elewski B. Fungal infections in HIV-infected patients. Sem Cut Med Surg 1997; 116: 200-12.